Fitness to Practise Cases

Pharmacist’s Conditions on Practice Extended After Dishonest COVID-19 Testing

Allegations This case concerns a pharmacist whose misconduct involved COVID-19 testing services, illegitimate Fit to Fly certificates, inadequate records and dishonest information supplied to a GPhC inspector. At the review hearing on 14 October 2026, the central question was whether the registrant had demonstrated sufficient remediation to return to unrestricted practice. The original findings included […]

15 October 2026

Methotrexate Dispensing Error Contributes to Patient’s Death: GPhC Issues Warning to Pharmacist

Allegations An elderly patient presented a handwritten prescription from a dermatologist for methotrexate and folic acid. Methotrexate was intended to be taken once weekly, on Mondays, with the dose increased each week. Folic acid was prescribed for Fridays. This combination of a specified administration day and an incremental regimen required careful interpretation, calculation and explanation […]

14 October 2026

Locum Pharmacist Struck Off After Deliberate Excess Methadone Supply and Serious Dispensing Failings

Allegations This case concerned a combination of deliberate excess methadone supply, inaccurate controlled drug records, dispensing errors and admitted workplace misconduct. The GPhC Fitness to Practise Committee heard the case remotely between 5 and 12 October 2026. The central allegation was that the registrant supplied a vulnerable patient, Patient A, with approximately 65 ml of […]

13 October 2026

Online Pharmacy Safety Failings: Pharmacist’s Conditions Extended After No Evidence of Remediation

Allegations An online pharmacy’s safety failures remained unresolved at a further fitness to practise review, with the committee receiving no evidence that the registrant had addressed the deficiencies identified at the original hearing. Although the committee considered suspension and removal, it decided that another 12 months of conditions remained proportionate and would give the registrant […]

GPhC Caution Disclosure Case Ends Without Dishonesty Findings After Committee Rules It Has No Jurisdiction

Allegations This case concerned an alleged failure to disclose a police caution to the GPhC, rather than a dispensing error, clinical incident or controlled drug handling concern. The central question was whether the Fitness to Practise Committee could consider alleged dishonest non-disclosure after the caution had acquired legal protection. The GPhC alleged that the registrant […]

12 October 2026

Pharmacist Who Dishonestly Took Medicines From Pharmacy Shows Sufficient Insight for Suspension to End

Allegations This case concerns a pharmacist whose dishonest removal of medicines from a community pharmacy led to misconduct findings and suspension. At a review hearing on 7 October 2026, the GPhC Fitness to Practise Committee considered whether the registrant had sufficiently addressed the concerns to return to practice when the existing suspension expired. The underlying […]

8 October 2026

Pharmacist’s Methadone Safety Failings and Dishonest Records: GPhC Ends Restrictions After Successful Remediation

Allegations This case concerned a community pharmacist whose fitness to practise had previously been found impaired following unsafe methadone practices and dishonest record keeping. The determination dated 17 May 2019 was a principal review hearing, held to assess whether the registrant had addressed the concerns that led to restrictions on their registration. At the original […]

6 October 2026

Pharmacy technician receives GPhC warning over chemotherapy ordering dishonesty and expired stock records

Allegations A pharmacy technician employed as an aseptic service technical manager at an NHS trust received a GPhC warning following concerns about a chemotherapy medication order and the recording of expired high-cost pharmacy stock. The first concern involved Abraxane, identified in the notice as a patient’s chemotherapy medication. The registrant omitted to order it. When […]

1 October 2026

Conditions of practice order for pharmacist after dishonesty involving controlled drugs, falsified records and inappropriate co-codamol supply

Allegations This case concerned a pharmacist who had worked for many years as a Responsible Pharmacist and store manager at a Boots pharmacy. The concerns arose after discrepancies were identified between controlled drug stock records and expected quantities of codeine held within the pharmacy. The investigation identified a discrepancy involving thousands of codeine tablets. During […]

28 September 2026

Superintendent pharmacist owner suspended after serious misconduct findings including dispensing water instead of Oramorph

Allegations This case concerned a pharmacist who was the part-owner and Superintendent Pharmacist of Harper’s Pharmacy in Brighton during the period January to August 2018. The concerns arose after Patient A, who was prescribed Oramorph (morphine oral solution) for pain associated with a prolapsed disc, reported concerns that medication supplied by the pharmacy did not […]

26 September 2026